These observations strongly support the view that germline BRCA2 mutations influence the accumulation of prostate cancer-associated genetic alterations in normal prostatic epithelium, thus favoring prostate cancer development and progression [30,418]. This evidence concerns the gene BRCA2 and prostate carcinoma.